Halle (Saale), 05.04.2023. Im Kampf gegen Parodontitis erhält PerioTrap Unterstützung vom Bundesministerium für Bildung und Forschung (BMBF). Mit insgesamt 3 Millionen Euro fördert das BMBF ein…

PerioTrap has published its efficient targeted periodontitis strategy that could minimize side effects and the overuse of broad-spectrum antibiotics.

PerioTrap has published its efficient targeted periodontitis strategy that could minimize side effects and the overuse of broad-spectrum antibiotics. It was developed and tested together with…


Team

PerioTrap Pharmaceuticals raises €3M seed round to develop selective anti-infectives to tackle periodontitis

Halle (Saale), 21.10.2020 – Although periodontitis is a widespread infectious disease affecting around 30% of the global population, there are currently no effective treatments available — yet.…


PerioTrap Pharmaceuticals ist Gesamtsieger des IQ Innovationspreis

Für die Kombination aus einem neuartigen Medikament und Therapieansatz zur Bekämpfung von Paradontitis auslösenden Keimen im Mundraum wurde die PerioTrap Pharmaceuticals GmbH aus Halle (Saale) mit…


Antimicrobial activity study has been published

After our mutual antimicrobial activity study has been published in April this year showing biofilm inhibition of our developed drug formulation, now the according paper detailing its optimized…